Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers

OBJECTIVE: To identify an early response criterion for predicting ≥5% weight loss with liraglutide 3.0 mg at week 56 and to compare efficacy outcomes in early responders (ERs) and early nonresponders (ENRs). METHODS: Using pooled data from the SCALE Obesity and Prediabetes and SCALE Diabetes trials,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujioka, Ken, O'Neil, Patrick M., Davies, Melanie, Greenway, Frank, C.W. Lau, David, Claudius, Birgitte, Skjøth, Trine Vang, Bjørn Jensen, Christine, P.H. Wilding, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Obesity Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129670/
https://www.ncbi.nlm.nih.gov/pubmed/27804269
http://dx.doi.org/10.1002/oby.21629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129670/
https://www.ncbi.nlm.nih.gov/pubmed/27804269
http://dx.doi.org/10.1002/oby.21629

Ejemplares similares